Patent · US Revoked

Substituted nucleosides, nucleotides and analogs thereof

US10421771B2 · kind B2 · utility

0Cited by
92References
27Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 2, 2015
Grant dateSep 24, 2019
Priority date
Expiry dateJul 2, 2035

Classification

  • Technology area (CPC —)General

Abstract

Disclosed herein are nucleosides, nucleotides and analogs thereof, pharmaceutical compositions that include one or more of nucleosides, nucleotides and analogs thereof, and methods of synthesizing the same. Also disclosed herein are methods of ameliorating and/or treating a disease and/or a condition, including an infection from a paramyxovirus and/or an orthomyxovirus, with a nucleoside, a nucleotide and an analog thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.